Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients

NCT01605890 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-2 Infection

Interventions

DRUG: emtricitabine / tenofovir disoproxil fumarate / raltegravir .

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]